Diabetes complications

Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial

Diabetes MetabPublished Randomised controlled trial

Authors' conclusion

In France, the addition of IFSG to the care plan of patients with deep diabetic foot wounds improved the closure rate by 41.6 % in IFSG group versus 22.2 % in SOC.

Study context

Population
Patients with University of Texas grade 2 and 3 Diabetic foot ulcers (DFUs), 8 centres in France179 in primary analysis
Participants
180 patients
Comparison
Intact fish skin graft vs local standard of care
Primary endpoint
Complete epithelialization
Follow-up
16 weeks
Methodological detailsmultinational, multicentre, French subgroup
  • Multinational
  • Multicentre
  • French subgroup

Primary result

As reported in the abstract

Complete epithelialization (closure rate)

P = 0.0053

Secondary outcomes

Graft applications among healed patients — Intact fish skin graft (IFSG)
median 7 graft applications
Mean relative wound area · week 6 · statistically significant difference · ITT analysis
P < 0.05

Complete epithelialization · 20 weeks

Proportion 2.11 times higher with IFSG vs standard of care (SOC)

Original publication

Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial. Diabetes Metab. Published 23 July 2025. doi:10.1016/j.diabet.2025.101691

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.